DXR: Daxor Corp Financial Statements

Balance sheet, income statement, and cash flow statements for Daxor Corp (DXR).

OverviewDividends

$38.33M Market Cap.

As of 06/14/2019 5:00 PM ET (MRY) • Disclaimer

DXR Market Cap. (MRY)


DXR Shares Outstanding (MRY)


DXR Assets (MRY)


Total Assets

$85.72M

Total Liabilities

$49.51M

Total Investments

$55.80M

DXR Income (MRY)


Revenue

$1.45M

Net Income

-$7.19M

Operating Expense

$6.58M

DXR Cash Flow (MRY)


CF Operations

-$6.51M

CF Investing

-$11.39M

CF Financing

$17.90M

DXR Balance Sheet (MRY)


Metric

2011

2010

2009

2008

Total Assets

$85,724,861 (-6.00%)

$91,195,415 (21.29%)

$75,186,990 (-2.13%)

$76,824,181 (-25.09%)

Assets Current

$81,686,352 (-6.10%)

$86,989,265 (22.56%)

$70,976,694 (-4.70%)

$74,478,468 (-25.87%)

Assets Non-Current

$4,038,509 (-3.99%)

$4,206,150 (-0.10%)

$4,210,296 (79.49%)

$2,345,713 (11.93%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$36,216,591 (-22.94%)

$46,995,044 (-1.32%)

$47,625,337 (9.58%)

$43,460,641 (-20.86%)

Property Plant & Equipment Net

$4,001,351 (-4.02%)

$4,168,992 (-0.10%)

$4,173,138 (80.77%)

$2,308,555 (12.15%)

Cash & Equivalents

$59,625 (3.26%)

$57,741 (-79.16%)

$277,088 (-89.11%)

$2,545,040 (25.38%)

Accumulated Other Comprehensive Income

$12,572,514 (-15.57%)

$14,890,272 (-7.03%)

$16,016,375 (39.77%)

$11,459,203 (-60.76%)

Deferred Revenue

$38,671 (-25.52%)

$51,920 (10.70%)

$46,902 (40.64%)

$33,349 (349.63%)

Total Investments

$55,804,364 (3.58%)

$53,876,071 (1.14%)

$53,270,726 (-22.05%)

$68,339,143 (-21.74%)

Investments Current

$55,804,364 (3.58%)

$53,876,071 (1.14%)

$53,270,726 (-22.05%)

$68,339,143 (-21.74%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$301,534 (-17.08%)

$363,634 (-19.98%)

$454,407 (6.46%)

$426,826 (66.84%)

Trade & Non-Trade Receivables

$23,298,459 (-28.45%)

$32,561,259 (93.01%)

$16,870,042 (455.75%)

$3,035,547 (-71.66%)

Trade & Non-Trade Payables

$525,168 (20.30%)

$436,542 (-18.19%)

$533,631 (-11.71%)

$604,420 (21.32%)

Accumulated Retained Earnings (Deficit)

$24,740,252 (-24.98%)

$32,980,341 (2.29%)

$32,241,597 (0.26%)

$32,158,138 (36.92%)

Tax Assets

$2,013,031 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$4,651,147 (-61.21%)

$11,990,746 (3.63%)

$11,570,426 (8.03%)

$10,710,781 (-37.08%)

Total Debt

$37,189,836 (35.77%)

$27,391,094 (145.41%)

$11,161,571 (-17.87%)

$13,590,631 (-43.71%)

Debt Current

$36,945,882 (36.38%)

$27,091,031 (150.50%)

$10,814,710 (-18.07%)

$13,200,339 (-44.33%)

Debt Non-Current

$243,954 (-18.70%)

$300,063 (-13.49%)

$346,861 (-11.13%)

$390,292 (-9.36%)

Total Liabilities

$49,508,270 (12.01%)

$44,200,371 (60.37%)

$27,561,653 (-17.39%)

$33,363,540 (-29.97%)

Liabilities Current

$49,264,316 (12.22%)

$43,900,308 (61.31%)

$27,214,792 (-17.46%)

$32,973,248 (-30.16%)

Liabilities Non-Current

$243,954 (-18.70%)

$300,063 (-13.49%)

$346,861 (-11.13%)

$390,292 (-9.36%)

DXR Income Statement (MRY)


Metric

2011

2010

2009

2008

Revenues

$1,446,345 (-8.42%)

$1,579,257 (-6.49%)

$1,688,826 (-4.10%)

$1,761,055 (-5.81%)

Cost of Revenue

$652,511 (-10.33%)

$727,650 (3.23%)

$704,866 (-1.73%)

$717,278 (5.05%)

Selling General & Administrative Expense

$3,874,296 (11.68%)

$3,469,078 (6.15%)

$3,267,997 (-14.28%)

$3,812,506 (-5.66%)

Research & Development Expense

$2,705,952 (-11.04%)

$3,041,640 (7.66%)

$2,825,151 (15.86%)

$2,438,423 (-5.37%)

Operating Expenses

$6,580,248 (1.07%)

$6,510,718 (6.85%)

$6,093,148 (-2.52%)

$6,250,929 (-5.54%)

Interest Expense

$168,923 (173.89%)

$61,676 (-62.16%)

$162,983 (10.50%)

$147,501 (-25.21%)

Income Tax Expense

-$5,142,076 (-252.05%)

$3,381,892 (154.45%)

$1,329,114 (-70.84%)

$4,557,964 (247.66%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$7,185,639 (-244.63%)

$4,968,264 (-14.68%)

$5,822,758 (-61.50%)

$15,123,269 (42.04%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$7,185,639 (-244.63%)

$4,968,264 (-14.68%)

$5,822,758 (-61.50%)

$15,123,269 (42.04%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$7,185,639 (-244.63%)

$4,968,264 (-14.68%)

$5,822,758 (-61.50%)

$15,123,269 (42.04%)

Weighted Average Shares

$4,219,654 (-0.41%)

$4,237,216 (-0.60%)

$4,262,643 (-2.03%)

$4,350,951 (-4.84%)

Weighted Average Shares Diluted

$4,219,654 (-0.41%)

$4,237,216 (-1.11%)

$4,284,643 (-2.08%)

$4,375,623 (-4.30%)

Earning Before Interest & Taxes (EBIT)

-$12,158,792 (-244.54%)

$8,411,832 (15.00%)

$7,314,855 (-63.11%)

$19,828,734 (63.13%)

Gross Profit

$793,834 (-6.78%)

$851,607 (-13.45%)

$983,960 (-5.73%)

$1,043,777 (-12.07%)

Operating Income

-$5,786,414 (-2.25%)

-$5,659,111 (-10.76%)

-$5,109,188 (1.88%)

-$5,207,152 (4.12%)

DXR Cash Flow Statement (MRY)


Metric

2011

2010

2009

2008

Net Cash Flow from Investing

-$11,388,438 (-221.13%)

$9,401,925 (-63.19%)

$25,539,873 (752.68%)

-$3,913,074 (-126.49%)

Net Cash Flow from Financing

$17,898,970 (555.31%)

-$3,931,189 (82.57%)

-$22,554,702 (-366.36%)

$8,467,705 (168.09%)

Net Cash Flow from Operations

-$6,508,648 (-14.39%)

-$5,690,083 (-8.32%)

-$5,253,123 (-30.05%)

-$4,039,425 (-28.52%)

Net Cash Flow / Change in Cash & Cash Equivalents

$1,884 (100.86%)

-$219,347 (90.33%)

-$2,267,952 (-540.20%)

$515,206 (163.68%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$15,810,589 (-600.91%)

$3,156,359 (-78.78%)

$14,872,739 (129.83%)

-$49,858,932 (-1474.20%)

Capital Expenditure

-$123,150 (52.58%)

-$259,710 (87.70%)

-$2,111,724 (-419.73%)

-$406,310 (71.92%)

Issuance (Repayment) of Debt Securities

$19,183,757 (3444.24%)

$541,265 (103.10%)

-$17,464,787 (-200.57%)

$17,365,984 (270.32%)

Issuance (Purchase) of Equity Shares

-$230,337 (5.19%)

-$242,934 (50.48%)

-$490,616 (79.94%)

-$2,445,777 (-9.23%)

Payment of Dividends & Other Cash Distributions

-$1,054,450 (75.07%)

-$4,229,520 (26.31%)

-$5,739,299 (11.05%)

-$6,452,502 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$9,731 (0%)

$0 (0%)

$14,681 (-77.89%)

$66,386 (51.09%)

Depreciation Amortization & Accretion

$290,791 (-1.94%)

$296,554 (6.33%)

$278,907 (-3.41%)

$288,748 (25.58%)

DXR Financial Metrics (MRY)


Metric

2011

2010

2009

2008

Gross Margin

54.90% (1.86%)

53.90% (-7.55%)

58.30% (-1.69%)

59.30% (-6.61%)

Profit Margin

-496.80% (-257.91%)

314.60% (-8.76%)

344.80% (-59.85%)

858.80% (50.83%)

EBITDA Margin

-820.60% (-248.82%)

551.40% (22.64%)

449.60% (-60.64%)

1142.40% (72.46%)

Return on Average Equity (ROAE)

-17.40% (-262.62%)

10.70% (-19.55%)

13.30% (-53.66%)

28.70% (42.08%)

Return on Average Assets (ROAA)

-7.90% (-236.21%)

5.80% (-27.50%)

8.00% (-53.22%)

17.10% (40.16%)

Return on Sales (ROS)

-840.70% (-257.85%)

532.60% (22.97%)

433.10% (-61.54%)

1126.00% (73.20%)

Return on Invested Capital (ROIC)

-15.70% (-228.69%)

12.20% (-2.40%)

12.50% (-58.19%)

29.90% (62.50%)

Dividend Yield

2.70% (-75.00%)

10.80% (-3.57%)

11.20% (15.46%)

9.70% (0%)

Price to Earnings Ratio (P/E)

-5.35 (-167.71%)

7.91 (-10.12%)

8.8 (98.78%)

4.42 (-29.53%)

Price to Sales Ratio (P/S)

26.55 (6.97%)

24.82 (-18.40%)

30.41 (-20.06%)

38.05 (6.36%)

Price to Book Ratio (P/B)

1.06 (27.16%)

0.83 (-22.60%)

1.07 (-29.46%)

1.52 (26.68%)

Debt to Equity Ratio (D/E)

1.37 (45.27%)

0.94 (62.52%)

0.58 (-24.61%)

0.77 (-11.52%)

Earnings Per Share (EPS)

-1.7 (-245.30%)

1.17 (-14.60%)

1.37 (-60.63%)

3.48 (49.36%)

Sales Per Share (SPS)

0.34 (-8.04%)

0.37 (-5.81%)

0.4 (-2.22%)

0.41 (-0.98%)

Free Cash Flow Per Share (FCFPS)

-1.57 (-11.97%)

-1.4 (18.75%)

-1.73 (-69.08%)

-1.02 (-1.79%)

Book Value Per Share (BVPS)

8.58 (-22.61%)

11.09 (-0.73%)

11.17 (11.85%)

9.99 (-16.83%)

Tangible Assets Book Value Per Share (TABVPS)

20.32 (-5.60%)

21.52 (22.01%)

17.64 (-0.10%)

17.66 (-21.29%)

Enterprise Value Over EBIT (EV/EBIT)

-6 (-185.71%)

7 (-22.22%)

9 (125.00%)

4 (-33.33%)

Enterprise Value Over EBITDA (EV/EBITDA)

-6.12 (-190.92%)

6.73 (-19.07%)

8.32 (114.91%)

3.87 (-34.74%)

Asset Turnover

0.02 (-11.11%)

0.02 (-21.74%)

0.02 (15.00%)

0.02 (-4.76%)

Current Ratio

1.66 (-16.35%)

1.98 (-24.00%)

2.61 (15.45%)

2.26 (6.16%)

Dividends

$0.25 (-75.00%)

$1 (-25.93%)

$1.35 (-10.00%)

$1.5 (0%)

Free Cash Flow (FCF)

-$6,631,798 (-11.46%)

-$5,949,793 (19.21%)

-$7,364,847 (-65.66%)

-$4,445,735 (3.14%)

Enterprise Value (EV)

$72,634,639 (23.91%)

$58,620,151 (-7.18%)

$63,156,609 (-18.87%)

$77,847,990 (5.99%)

Earnings Before Tax (EBT)

-$12,327,715 (-247.63%)

$8,350,156 (16.75%)

$7,151,872 (-63.66%)

$19,681,233 (64.58%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$11,868,001 (-236.28%)

$8,708,386 (14.68%)

$7,593,762 (-62.25%)

$20,117,482 (62.43%)

Invested Capital

$73,590,756 (-1.39%)

$74,628,460 (26.80%)

$58,856,681 (7.21%)

$54,896,524 (-29.13%)

Working Capital

$32,422,036 (-24.76%)

$43,088,957 (-1.54%)

$43,761,902 (5.44%)

$41,505,220 (-22.06%)

Tangible Asset Value

$85,724,861 (-6.00%)

$91,195,415 (21.29%)

$75,186,990 (-2.13%)

$76,824,181 (-25.09%)

Market Capitalization

$38,334,769 (-1.95%)

$39,098,242 (-23.66%)

$51,218,742 (-22.69%)

$66,254,157 (0.26%)

Average Equity

$41,379,015 (-10.54%)

$46,252,855 (5.72%)

$43,750,492 (-16.83%)

$52,606,183 (-0.00%)

Average Assets

$90,720,286 (5.28%)

$86,166,581 (18.03%)

$73,006,225 (-17.58%)

$88,582,740 (1.47%)

Invested Capital Average

$77,310,922 (11.71%)

$69,207,529 (18.29%)

$58,506,604 (-11.71%)

$66,268,364 (0.41%)

Shares

4,212,612 (-0.34%)

4,226,837 (-0.56%)

4,250,518 (-1.20%)

4,302,218 (-4.75%)